Journal article
Cell therapy commercialization: An assessment of translational barriers
- Abstract:
- Cellular based therapies represent a platform technology within the rapidly expanding field of regenerative medicine and are distinct from conventional therapeutics - offering a unique approach to managing what were once considered untreatable diseases.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 317.8KB)
-
- Publisher copy:
- 10.1016/S1525-0016(16)33526-2
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- American Society of Gene and Cell Therapy 19th Annual Meeting Journal website
- Publication date:
- 2016-12-01
- Acceptance date:
- 2016-03-14
- DOI:
- ISSN:
-
1525-0016
Item Description
- Pubs id:
-
pubs:812867
- UUID:
-
uuid:03b85a38-c032-4b82-b031-ec56a329b197
- Local pid:
- pubs:812867
- Source identifiers:
-
812867
- Deposit date:
- 2017-12-26
Terms of use
- Copyright holder:
- American Society of Gene and Cell Therapy
- Copyright date:
- 2016
- Notes:
- Copyright © The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. Under a Creative Commons license
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record